Skip to main content
Year archive

Keymed Biosciences Inc. — 2023 filings

All 70 regulatory filings released by Keymed Biosciences Inc. (2162) in 2023, sourced directly from the official regulator.

70 Filings
2023 Period
2023 filings (70)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF CM310 FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS ACHIEVED PRIMARY ENDPOINTS
Regulatory Filings
2023-12-27 English
Interim Report 2023/24
Regulatory Filings
2023-12-07 English
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF STAPOKIBART FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN ADULTS ACCEPTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2023-12-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-01 English
Cash Dividend Announcement for Equity Issuer
Notice of Dividend Amount
2023-11-24 English
ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Interim / Quarterly Report
2023-11-24 English
Date of Board Meeting
Regulatory Filings
2023-11-13 English
PROFIT WARNING
Regulatory Filings
2023-11-08 English
VOLUNTARY ANNOUNCEMENT THE LATEST RESULTS FROM A PHASE I CLINICAL STUDY OF CMG901 AT THE ASCO PLENARY SERIES BY WAY OF ORAL PRESENTATION
Regulatory Filings
2023-11-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Share Issue/Capital Change
2023-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings
2023-11-01 English
List of Directors and their Role and Function
Board/Management Information
2023-10-13 English
VOLUNTARY ANNOUNCEMENT CM310 PHASE III CLINICAL TRIAL TOPLINE DATA ACCEPTED FOR POSTER SESSION AT THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) CONGRESS 2023
Regulatory Filings
2023-10-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-04 English
List of Directors and their Role and Function
Board/Management Information
2023-09-29 English
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND A MEMBER OF AUDIT COMMITTEE, REMUNERATION COMMITTEE AND NOMINATION COMMITTEE
Board/Management Information
2023-09-29 English
2023 INTERIM REPORT
Interim / Quarterly Report
2023-09-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 August 2023
Regulatory Filings
2023-09-04 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Interim / Quarterly Report
2023-08-24 English
DATE OF BOARD MEETING
Regulatory Filings
2023-08-11 English
RESULTS OF ANNUAL GENERAL MEETING HELD ON 10 AUGUST 2023
Declaration of Voting Results & Voting Rights Announcements
2023-08-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-01 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-07-10 English
Proxy form for use at the Annual General Meeting to be held on Thursday, 10 August 2023 at 3:00 p.m. or at any adjournment thereof
AGM Information
2023-07-10 English
PROPOSALS FOR RE-ELECTION OF DIRECTORS, GRANT OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-07-10 English
ANNUAL REPORT 2022/23
Regulatory Filings
2023-07-10 English
Environmental, Social and Governance Report 2022/23
Regulatory Filings
2023-07-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-03 English
List of Directors and their Role and Function
Board/Management Information
2023-06-30 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2023
Annual Report
2023-06-28 English
SPECIAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2023
Notice of Dividend Amount
2023-06-28 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2023
Notice of Dividend Amount
2023-06-28 English
CHANGE OF CHIEF EXECUTIVE OFFICER AND REDESIGNATION OF DIRECTOR AND RESIGNATION OF DEPUTY CHAIRMAN
Board/Management Information
2023-06-28 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2023-06-27 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 27, 2023
Declaration of Voting Results & Voting Rights Announcements
2023-06-27 English
CONNECTED AND DISCLOSEABLE TRANSACTION ACQUISITION OF REMAINING EQUITY INTEREST IN A NON-WHOLLY OWNED SUBSIDIARY
Capital/Financing Update
2023-06-26 English
DATE OF BOARD MEETING
Regulatory Filings
2023-06-15 English
VOLUNTARY ANNOUNCEMENT CM313 PHASE I CLINICAL STUDY DATA ACCEPTED FOR POSTER SESSION AT THE 28TH EUROPEAN HEMATOLOGY ASSOCIATION (EHA) CONGRESS 2023
Regulatory Filings
2023-06-12 English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY DIRECTOR AND SUBSTANTIAL SHAREHOLDER
Director's Dealing
2023-06-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Major Shareholding Notification
2023-06-01 English
VOLUNTARY ANNOUNCEMENT LATEST DEVELOPMENT ON PHASE III CLINICAL TRIAL OF CM310 FOR THE TREATMENT OF MODERATE TO SEVERE ATOPIC DERMATITIS IN ADULTS
Regulatory Filings
2023-05-30 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-02 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information
2023-04-24 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-04-24 English
(1) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; (2) RE-ELECTION OF DIRECTORS&#x3b; (3) RE-APPOINTMENT OF AUDITOR&#x3b; AND (4) NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-04-24 English
2022 ANNUAL REPORT
Annual Report
2023-04-24 English
RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF COMPOSITION OF THE AUDIT COMMITTEE AND NOMINATION COMMITTEE
Board/Management Information
2023-04-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-03 English
VOLUNTARY ANNOUNCEMENT PRIMARY STUDY ENDPOINTS FROM PHASE III CLINICAL TRIAL OF CM310 FOR THE TREATMENT OF MODERATE TO SEVERE ATOPIC DERMATITIS IN ADULTS
Regulatory Filings
2023-03-28 English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
Remuneration Information
2023-03-17 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
Annual Report
2023-03-17 English
DATE OF BOARD MEETING
Report Publication Announcement
2023-03-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Major Shareholding Notification
2023-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings
2023-03-01 English
ANNOUNCEMENT PURSUANT TO RULE 13.51B(2) OF THE LISTING RULES
Board/Management Information
2023-02-24 English
INSIDE INFORMATION EXCLUSIVE LICENSE AGREEMENT WITH ASTRAZENECA FOR CMG901
Regulatory Filings
2023-02-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-01 English
DISCLOSEABLE TRANSACTION ACQUISITION OF THE LAND USE RIGHTS OF THE LAND LOCATED IN CHENGDU, SICHUAN PROVINCE
Capital/Financing Update
2023-01-18 English
VOLUNTARY ANNOUNCEMENT THE LATEST RESULTS FROM THE PHASE IA CLINICAL STUDY OF CMG901 AT THE 2023 ASCO GI CANCERS SYMPOSIUM
Regulatory Filings
2023-01-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Share Issue/Capital Change
2023-01-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-03 English